Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1999 Mar;43(3):454-9.
doi: 10.1128/AAC.43.3.454.

In vitro activities of aminomethyl-substituted analogs of novel tetrahydrofuranyl carbapenems

W J Weiss  1 , P J Petersen, N V Jacobus, Y I Lin, P Bitha, R T Testa
Affiliations

In vitro activities of aminomethyl-substituted analogs of novel tetrahydrofuranyl carbapenems

W J Weiss et al. Antimicrob Agents Chemother. 1999 Mar.

Abstract

CL 188,624, CL 190,294, and CL 191,121 are novel aminomethyl tetrahydrofuranyl (THF)-1 beta-methylcarbapenems. The in vitro antibacterial activities of these THF carbapenems were evaluated and compared with those of biapenem, imipenem, and meropenem against 554 recent clinical isolates obtained from geographically distinct medical centers across North America. The antibacterial activities of the THF carbapenems were equivalent to that of biapenem, and the THF carbapenems were slightly more active than imipenem and less active than meropenem against most of the members of the family Enterobacteriaceae but lacked significant activity against Pseudomonas isolates. In general, CL 191,121 was two- to fourfold more active than CL 188,624 and CL 190,294 against the staphylococcal and enterococcal isolates tested. CL 191,121 was twofold less active than imipenem against methicillin-susceptible staphylococci and was as activity as imipenem against Enterococcus faecalis isolates. Biapenem and meropenem were two- and fourfold less active than CL 191,121, respectively, against the methicillin-susceptible staphylococci and E. faecalis. All the carbapenems displayed equivalent good activities against the streptococci. Biapenem was slightly more active than the other carbapenems against Bacteroides fragilis isolates. Time-kill curve studies demonstrated that the THF carbapenems were bactericidal in 6 h against Escherichia coli and Staphylococcus aureus isolates. The postantibiotic effect exerted by CL 191,121 was comparable to or slightly longer than that of imipenem against isolates of S. aureus, E. coli, and Klebsiella pneumoniae.

PubMed Disclaimer

Figures

FIG. 1
FIG. 1
Structures of the aminomethylTHF 1β-methylcarbapenems.
FIG. 2
FIG. 2
Antibacterial activities of carbapenems against E. coli 311.
FIG. 3
FIG. 3
Antibacterial activities of carbapenems against S. aureus Smith.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Bush K, Bhachech N, Yang Y, Weiss W, Lin Y, Testa R, Tally F. Program and abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, D.C: American Society for Microbiology; 1994. Binding to penicillin-binding proteins (PBPs) and permeability of novel THF carbapenems, abstr. F76; p. 128.
    1. Craig W, Gudmundsson S. The postantibiotic effect. In: Lorian V, editor. Antibiotics in laboratory medicine. 2nd ed. Baltimore, Md: The Williams & Wilkins Co.; 1986. pp. 515–536.
    1. Fukuoka T, Ohya S, Utsui Y, Domon H, Takenouchi T, Koga T, Masuda N, Kawada H, Kakuta M, Kubota M, Ishii C, Ishii C, Sakagawa E, Harasaki T, Hirasawa A, Abe T, Yasuda H, Iwata M, Kuwahara S. In vitro and in vivo antibacterial activities of CS-834, a novel oral carbapenem. Antimicrob Agents Chemother. 1997;41:2652–2663. - PMC - PubMed
    1. Graham D, Ashton W, Barash L, Canning L, Chen A, Springer J, Rogers E. Inhibition of the mammalian β-lactamase renal dipeptidase by (Z)-2-(acyclamido)-3-substituted-propenoic acids. J Med Chem. 1987;30:1074–1090. - PubMed
    1. Hashizume T, Shibata K, Nagano R, Adachi Y, Nakamura K, Fuse A, Kato Y, Hazumi N, Asano K, Naito T, Ishihara A, Sawaasaki Y, Nishino M, Uchida M, Nagami K, Samura K. Program and abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, D.C: American Society for Microbiology; 1996. In vitro and in vivo evaluation of BO-3482, a novel dithiocarbamate carbapenem, abstr. F118; p. 120.

LinkOut - more resources